Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Running, not enrolling · Not applicable

Conditions studied: Aphakia, Astigmatism, Presbyopia

In brief

The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.

Key facts

Study ID

NCT05796453

Run by

Alcon Research

People needed

470

Starts

2023-09-19

Expected to finish

2028-06-01

Last updated by the study team

2025-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Wolstan & Goldberg Eye Associates — Torrance, California, United States
• Levenson Eye Associates — Jacksonville, Florida, United States
• Eye Surgeons of CNY — Liverpool, New York, United States
• Tulsa Ophthalmology — Tulsa, Oklahoma, United States
• Chu Eye Institute — Fort Worth, Texas, United States
• The Eye Institute of Utah — Salt Lake City, Utah, United States
• Centro Oftalmologico Metropolitano — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.